Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




High Lithium Levels Adversely Affect Renal Function

By HospiMedica International staff writers
Posted on 25 Nov 2014
A new study reveals that Lithium (Li), a mainstay treatment for patients with bipolar disorder, can cause acute kidney damage, even during a short-term exposure. More...


Researchers at the University of East Anglia (UEA; Norwich, United Kingdom) and the Norfolk and Suffolk NHS Foundation Trust (Norwich, United Kingdom) conducted a study involving 699 patients from the Norfolk-wide lithium register and database to determine associations between short-term exposure to elevated Li levels and estimated-glomerular filtration rate (eGFR) at 3, 6, and 12 months follow-up. The Li levels were 0.81–1.0, 1.01–1.2, and 1.21–2.0 mmol/L, with a reference group whose Li levels never exceeded 0.8 mmol/L.

The results showed that a single incident of a lithium level higher than 1 mmol/L was associated with a significant decrease in eGFR in the following 3 months, compared to patients whose Li levels never exceeded 0.8 mmol/L; kidney function remained affected for up to nine months after exposure to a high Li level. The researchers are currently exploring the effects of multiple exposures to high lithium levels on kidney function. The study was published on November 7, 2014, in BJM Open.

“A single exposure to a lithium level greater than 1.0 mmol/L is associated with an increased risk of kidney function impairment in the following three months and that the higher the level, the greater the effect,” said lead author Emma Kirkham, PhD, of UEA School of Pharmacy. “This highlights the need for regular monitoring undertaken at least every three months, and that monitoring should not be reduced further until the impact of more than one high-level of lithium has been fully established.”

Recently, the UK National Institute for Health and Care Excellence (NICE; London, United Kingdom) changed its recommendation that Li levels should be checked every six months, a reduction from the previous recommendation of checking Li levels every three months. The results of the study strongly support monitoring be undertaken at least every three months, in line with other guidelines, and not be reduced.

Related Links:

University of East Anglia
Norfolk and Suffolk NHS Foundation Trust
UK National Institute for Health and Care Excellence



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.